Biomanufacturing?Implementing high-quality process development that considers GMP manufacturing from the start is critical to reducing costs and timeline disruptions associated with raw material supply chain insecurity, adhering to regulatory compliance, and avoiding process re-design at a later stage.
Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies.
At the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins.
Taking samples during bioprocessing is an integral part of quality control. It allows to gather information about culture growth, medium conditions, as well as metabolite or product concentrations. Ideally, sampling should take place regularly and in equal intervals. However, for manual sampling this often involves extra work at night or during weekends. Here, automated sampling is an attractive alternative, freeing up time for other tasks or just a relaxing weekend. The Eppendorf Bioprocess Autosampler is offering exactly that freedom by allowing 24/7 sampling and safe storage of your valuable culture snapshots.
Biotech innovator Biosyntia ApS, the latest addition to the ECBF, is applying proprietary biological processes to produce sustainable nutritional ingredients – a mission that has captured the imagination of seasoned biotech investors and major ingredient players.
Steve Jones took over the role of Chief Financial Officer (CFO) at the biotech company Ingenza Ltd (UK) at the beginning of April. He brings many years of experience and expertise in finance, having held a variety of senior positions.
Wellcome Sanger Institute spin out Mosaic Therapeutics has closed a $28m series A funding led by Syncona Investment Management Ltd, and Cambridge Innovation Capital.
French enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Precision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
BioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets.